Subjects with non-obese NAFLD had higher ALT, γ-GT, TG, Alb, UA, Hb, FBG and HbA1c, and lower HDL-C than subjects in the control group (p < 0.05). The gene discussed is GSTM1; the disease is metabolic dysfunction-associated steatotic liver disease.